Article Sidebar

PDF
Date Published: 03/05/2024
Abstract Views: 72
Views PDF: 64
DOI: https://doi.org/10.56535/jmpm.v49.806
Issue
Vol. 49 (2024): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ - SỐ ĐẶC BIỆT 5/2024
Section
CDHA
How to Cite
Hoang, D. A., Nguyễn, T. H. O., Lê, V. P., Nguyễn, M. H., Nguyễn, T. H. O., Phạm, T. D. H., Nguyễn, V. T., & Hoàng, Đ. K. (2024). NGHIÊN CỨU MỐI LIÊN QUAN GIỮA MỨC ĐỘ XƠ HOÁ GAN TRÊN SIÊU ÂM FIBROSCAN VỚI MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÝP 2. Journal of Military Pharmaco-medicine, 49, 172-179. https://doi.org/10.56535/jmpm.v49.806

NGHIÊN CỨU MỐI LIÊN QUAN GIỮA MỨC ĐỘ XƠ HOÁ GAN TRÊN SIÊU ÂM FIBROSCAN VỚI MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÝP 2

Hoang Dinh Anh , Thị Hoàng Oanh Nguyễn, Văn Phúc Lê, Minh Hải Nguyễn, Thị Hoàng Oanh Nguyễn, Thị Diệu Hương Phạm, Vũ Thắng Nguyễn, Đình Khánh Hoàng

Main Article Content

Abstract

Studying the relationship of Liver Stiffness Measurement on fibroscan with Clinic and paraclinic characteristics in patients with type 2 diabetes


Abstract:


- Objective: To investigate the relationship of Liver Stiffness Measurement on fibroscan with Clinic and paraclinic characteristics in patients with type 2 diabetes


- Subjects and methods: Cross-sectional and prospective description of 142 type 2 diabetes patients undergoing Fibroscan ultrasound at Military Hospital 103 from April 2023 to February 2024.


- Results: The Liver Stiffness Measurement (LSM) had no relationship with age, Gender, BMI, Blood pressure, HbA1c, Cholesterol, Triglyceride and AST, ALT index. The LSM in the increase blood Glucose patient group (6,8 ± 3,7 Kpa) increased higher than in the controlled  blood Glucose patient group (5,1 ± 1,6 Kpa). LSM have a moderate positive correlation with blood glucose r = 0.27, p < 0.05.


- Conclusion:  The Liver Stiffness Measurement on Fibroscan is related to blood glucose in patients with type 2 diabetes


- Keywords: Liver Stiffness Measurement, Fibroscan, Type 2 diabetes.

Article Details

Keywords

Liver Stiffness Measurement, type 2 diabetes

References

1. Tapper Elliot B, Castera Laurent, Afdhal Nezam H. FibroScan (vibration- controlled transient elastography): Where does it stand in the United States practice. Clinical Gastroenterology Hepatology. 2015; 13(1):27-36.
2. Mikolasevic Ivana, Orlic Lidija, Franjic Neven, et al. Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World Journal of Gastroenterology. 2016; 22(32):7236.
3. Wong Vincent Wai-Sun, Vergniol Julien, Wong Grace Lai-Hung, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010; 51(2):454-462.
4. Trần Thị Khánh Tường, Phạm Quang Thiên Phú. Mối tương quan giữa mức độ nhiễm mỡ gan và xơ hóa gan ở bệnh nhân đái tháo đường týp 2 bị bệnh gan nhiễm mỡ không do rượu. Tạp chí Y học Việt Nam. 2020; 488(1): 21-25.
5. Lomonaco Romina, Godinez Leiva Eddison, Bril Fernando, et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: The need for systematic screening. Diabetes Care. 2021; 44(2):399-406.
6. Kumar Nikhil A, Das Sidhartha. Fibroscan of Liver in type 2 diabetes mellitus and its correlation with risk factors. Journal of Diabetes Mellitus. 2019; 9(02):62-68.
7. Fabrellas Nuria, Hernandez Rosario, Graupera Isabel, et al. Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study. PloS one. 2018; 13(9):0200656.
8. Sporea Ioan, Mare Ruxandra, Popescu Alina, et al. Screening for liver fibrosis and steatosis in a large cohort of patients with type 2 diabetes using vibration controlled transient elastography and controlled attenuation parameter in a single-center real-life experience. Journal of Clinical Medicine. 2020; 9(4):1032.
9. Fernando Joseph Noel, Alba Rebecca Lim, Alba Willy. Factors associated with the severity of findings on hepatic transient elastography among persons with type 2 diabetes and fatty liver. Journal of the ASEAN Federation of Endocrine Societies. 2019; 34(2):134.